FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

2.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

3.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

4.

Global inequalities found in cancer research funding

5.

Certain surgical gestures during prostate removal linked to better sexual function recovery


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot